These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15990127)

  • 21. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
    Hedblad B; Nerbrand C; Ekesbo R; Johansson L; Midlöv P; Brunkstedt I; Svensson P; Gyllerup S; Sträng B; Persson R; Janzon L
    Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination of methyldopa and diuretics in the treatment of hypertensive disease].
    Dzúriková V; Krechnáková A; Szalayová V; Dzúrik R
    Vnitr Lek; 1985 Jan; 31(1):7-14. PubMed ID: 3969793
    [No Abstract]   [Full Text] [Related]  

  • 25. Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4).
    Tardif JC; Curnew GP; Leclerc JM; Rehel B
    Can J Clin Pharmacol; 2008; 15(2):e177-87. PubMed ID: 18515919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T; Yalçin AU
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB; Cleveland JM; Rolleri RL;
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical care and health care utilization in an HMO.
    Fischer LR; Defor TA; Cooper S; Scott LM; Boonstra DM; Eelkema MA; Goodman MJ
    Eff Clin Pract; 2002; 5(2):49-57. PubMed ID: 11990212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pharmacist intervention on control of resistant hypertension.
    Morse GD; Douglas JB; Upton JH; Rodgers S; Gal P
    Am J Hosp Pharm; 1986 Apr; 43(4):905-9. PubMed ID: 3706334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.
    Santschi V; Rodondi N; Bugnon O; Burnier M
    Eur J Intern Med; 2008 Oct; 19(6):427-34. PubMed ID: 18848176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of care of hypertension in three clinical settings in Jamaica.
    Wilks R; Sargeant LA; Gulliford M; Reid M; Forrester T
    West Indian Med J; 2000 Sep; 49(3):220-5. PubMed ID: 11076214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistant hypertension revisited: a comparison of two university-based cohorts.
    Garg JP; Elliott WJ; Folker A; Izhar M; Black HR;
    Am J Hypertens; 2005 May; 18(5 Pt 1):619-26. PubMed ID: 15882544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome analysis of a pharmacist-managed anticoagulation service.
    Wilt VM; Gums JG; Ahmed OI; Moore LM
    Pharmacotherapy; 1995; 15(6):732-9. PubMed ID: 8602380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.